Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J D Hoyer
WHO-defined ‘Myelodysplastic Syndrome With Isolated Del(5q)’ in 88 Consecutive Patients: Survival Data, Leukemic Transformation Rates and Prevalence of JAK2, MPL and IDH Mutations
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Multiple Myeloma With Concomitant JAK2-positive Essential Thrombocythemia Post-Successful Autologous Peripheral Blood Hematopoietic Stem Cell Transplant
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
JAK2 and MPL Mutations in Myeloproliferative Neoplasms: Discovery and Science
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Acute Leukemic Transformation of Myelodysplastic Syndrome: Is Cytochemistry Still Relevant?
American Journal of Hematology
Hematology
Cryptic 5q Deletion in a Patient With Myelodysplastic Syndrome
British Journal of Haematology
Hematology
JAK2, CALR, and MPL Mutation Spectrum in Japanese Patients With Myeloproliferative Neoplasms
Haematologica
Hematology
Blood Consult: Treating Del(5q) Myelodysplastic Syndromes
Blood
Biochemistry
Immunology
Cell Biology
Hematology
The 2016 Revised World Health Organization Definition of ‘Myelodysplastic Syndrome With Isolated Del(5q)’; Prognostic Implications of Single Versus Double Cytogenetic Abnormalities
British Journal of Haematology
Hematology
Unusual Clonal Evolution Involving 5q in a Case of Myelodysplastic Syndrome With Deletion 5q 31 Treated With Lenalidomide
Haematologica
Hematology
Response to Erythropoiesis‐stimulating Agents in Patients With WHO‐defined Myelodysplastic Syndrome/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis (MDS/MPN‐RS‐T)
British Journal of Haematology
Hematology
Lenalidomide in 5q Minus Myelodysplastic Syndrome: How Long Is Enough?
Annals of Hematology
Medicine
Hematology
